CNC — Centene Corporation
Is CNC overbought or oversold? Here is the current MarketMoodz read.
Centene Corporation (CNC) currently reads Neutral on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The Healthcare name (Healthcare Plans) last closed at $72.55. The rating moved from Overbought to Neutral on November 16, 2026.
- Public ratingNeutral (as of November 17, 2026)
- Last close$72.55
- Last changeMoved from Overbought to Neutral on November 16, 2026
- SectorHealthcare
- IndustryHealthcare Plans
AI analysis
Centene is a large, diversified managed-care operator with stable enrollment-driven revenues and scale advantages in Medicaid and growing presence in Medicare Advantage. Near-term outlook is clouded by CMS proposals that raise compliance and RADV risk and could erode MA economics if enforcement leads to clawbacks or higher verification costs. Ongoing diversification into specialty services and behavioral health, plus solid cash flow, offer path to margin recovery over time, but execution and regulatory outcomes will determine near-term earnings volatility. Social sentiment and market flows are neutral; absent clear regulatory clarity or positive operational beats, price action is likely to track sector consolidation.
Key factors
- Scale and diversified membership across Medicaid, Medicare Advantage and commercial segments provides stable revenue base and enrollment-driven cash flows
- Recent CMS proposals increasing program integrity and RADV scrutiny raise near-term regulatory/compliance costs and potential for clawbacks, pressuring MA economics
- Strong network and state-level relationships support Medicaid positioning and retention in managed Medicaid programs
- Ongoing efforts to diversify into behavioral health, specialty services and value-based care provide medium-term margin upside and revenue diversification
- Reasonable balance sheet and cash flow generation enabling operational investment and potential M&A, but sensitive to claims volatility
- Market environment is muted with consolidation themes; defensive healthcare flows may limit downside but not drive strong upside absent positive catalysts
Risks
- Heightened regulatory risk from CMS proposals (RADV audits, anti-fraud measures) leading to higher compliance costs and potential overpayment clawbacks
- Adverse medical cost trends or unusually high utilization causing margin compression in both Medicaid and Medicare Advantage books
- Competitive pricing pressure in Medicare Advantage from aggressive $0-premium benefit expansions by peers, narrowing underwriting margins
- Execution risk on diversification initiatives and post‑merger integration if M&A activity accelerates
- Policy and funding uncertainty around Medicaid/CHIP at the state or federal level affecting enrollment or reimbursement
- Litigation, audit exposure or large reserve adjustments that materially affect earnings or cash flow timing
Latest MarketMoodz coverage
- Centene Sees Membership Slide, Offers Voluntary Staff Buyouts2026-06-16
- Centene Offers Employee Buyouts as Membership and Funding Pressure Mount2026-06-15
- Dividend hopefuls could outperform if they initiate payouts, Morgan Stanley says2026-05-29
- Vance Admin Halts Minnesota Medicaid Reimbursements Amid Allegations2026-02-26
See today's live rating, score and targets
Members see the live hourly rating for CNC — the numeric AI score plus targets and entry zones — while this public page updates nightly.
Start the 14-day trialThis page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.